DDW's Diana Spencer explores the European Commission's proposed changes to EU pharmaceutical legislation, the reaction from industry and possible impact on smaller companies. The European Commission (EC) has proposed the largest reform to the EU's pharmaceutical legislation in over 20 years. The EC says the revisions will make the system more agile, flexible, and adapted to the needs […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!